Cloud Banner

Healthcare

Image

Global Autism Therapy Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Mar 2023
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Autism Therapy Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - 6.6000000000000005% Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 2.05 Billion
Diagram Market Size (Forecast Year) USD 3.42 Billion
Diagram CAGR 6.6000000000000005%

Global Autism Therapy Market, By Age Group (Child, Adult), Type (Asperger Syndrome, Pervasive Developmental Disorder, Autistic Disorder), Treatment Type (ABA, Hyperbaric Oxygen Therapy, Chelation Therapy, Oxytocin Therapy, Others), Drug (Anticonvulsants, Antipsychotics, Insomnia Drugs, SSRIs, Stimulants, Others), Distribution Channel (Hospital & Clinics, Retail Pharmacies, Online Pharmacies) – Industry Trends and Forecast to 2030.

Autism Therapy Market Analysis and Size

The growing incidence of autism and pervasive developmental disorder (PDD) is essential to escalate market growth. Huge research studies performed by organizations to assess the safety and efficiency of drugs in patients with ASD are anticipated to boost market growth. The stimulants segment dominated the market with a huge revenue share due to the wide availability and ease of accessibility of drugs to patients.

Data Bridge Market Research analyses that the autism therapy market, which was USD 2.05 billion in 2022, would rise to USD 3.42 billion by 2030 and is expected to undergo a CAGR of 6.60% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Autism Therapy Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Age Group (Child, Adult), Type (Asperger Syndrome, Pervasive Developmental Disorder, Autistic Disorder), Treatment Type (ABA, Hyperbaric Oxygen Therapy, Chelation Therapy, Oxytocin Therapy, Others), Drug (Anticonvulsants, Antipsychotics, Insomnia Drugs, SSRIs, Stimulants, Others), Distribution Channel (Hospital & Clinics, Retail Pharmacies, Online Pharmacies)

Countries Covered

U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Pfizer Inc.(U.S.), Lilly (U.S.), Abbvie, Inc (U.S.), Merck & Co., Inc (U.S.)., Teva Pharmaceutical Industries Ltd.(Israel), Novartis AG (Switzerland), Johnson & Johnson Services, Inc (U.S.)., Hopebridge, LLC (U.S.)., Bristol-Myers Squibb Company (U.S.), Otsuka America Pharmaceutical, Inc (Japan)., Curemark, LLC (U.S.)., Sosei Group Corporation (Japan), Sun Pharmaceutical Industries Ltd. (India), Mylan N.V. (U.S.)., Endo International plc (Ireland), and F. Hoffmann-La Roche Ltd (Switzerland)

Market Opportunities

  • Increasing Demand for Stimulants
  • Increasing Product Launches

Market Definition

Autism therapies are the type of therapies that are applied in autistic children or adults to improve or enhance their condition. Different therapies include speech-language therapy, behavior therapy, play-based therapy, occupational therapy, physical therapy, and nutritional therapy. This neurological disorder is related to several disabilities, such as challenges with the individual's behavior or lack of social skills. The diagnosis of autism can be made from a very early age, but the cause is still unknown.

Global Autism Therapy Market Dynamics

Drivers

  • Increasing Rate of Autistic Population

The increasing incidence of the autistic population is boosting the market's growth. For instance, France and Portugal have the lowest rates of autism in the world, with approximately 0.69% and 0.71%, respectively, as per the research published by Health Data Exchange. In 2021, the CDC stated that nearly 1 in 44 children in the U.S. is diagnosed with an autism spectrum disorder (ASD). Thus, this increasing prevalence demands high adoption of therapies, boosting the market growth.

  • Increasing R&D Activities Associated with Autism Therapy

Huge research studies performed by organizations to assess the safety and efficacy of drugs in patients with ASD are anticipated to drive the market. The positive outcomes of these studies lead to new growth opportunities for the market. For instance, Stalicla completed phase 1b trials of precision medicine candidate STP1 and witnessed positive results with symptom improvement in patients with ASD in 2022. Therefore, the effective completion of the trial and following product approvals are estimated to drive the market. Thus, this factor boosts market growth.

Opportunities

  • Increasing Demand for Stimulants

The increasing demand for stimulants is boosting the growth of the market. Adderall, Focalin, Vyvanse, Dexedrine, and Ritalin are some stimulants approved by the U.S. FDA for treating patients who have autism. These drugs improve patient behavior by 80% when administered properly to patients. Therefore, growing efficiency related to the stimulants may attract a new target population and boost market growth.  

  • Increasing Product Launches

A growing number of product launches associated with autism therapy boost market growth. For instance, the FDA granted fast-track designation to Curemark's CM-AT specified for ASD in 3-8 years old children in 2022. Furthermore, Indian researchers developed the 6BIO compound in 2021, which has shown the potential to enhance daily activities in the pre-clinical investigation of patients with an autism spectrum disorder. Thus, this factor boosts market growth.

Restraints/Challenges

  • High Cost of Autism therapy

The huge cost of various autistic therapies and their repeated sessions impede the market growth. Therapies such as behavioral, educational, developmental, and proper counseling sessions offer a huge cost range. For many potential users, particularly those with low financial means, the cost of these therapies may be a big factor. Therefore, these factors hamper the market growth.

This autism therapy market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the autism therapy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In 2022, Bened Life launched the first gut-brain medical probiotic named Neuralli. Neuralli is designed to raise awareness about mental health and support neurological conditions including but not limited to Parkinson's disease (P.D.) and autism spectrum disorder (ASD).
  • In 2022, STALICLA, a Swiss clinical-stage biotech company leading omics-based drug development for patients with neurodevelopmental disorders (NDDs), stated the highly successful completion of the phase 1b trials for its lead drug candidate STP1.

Global Autism Therapy Market Scope

The autism therapy market is segmented on the basis of age group, type, treatment type, drug and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Age Group

  • Child
  • Adult

Type

  • Asperger Syndrome
  • Pervasive Developmental Disorder
  • Autistic Disorder

Treatment Type

  • ABA
  • Hyperbaric Oxygen Therapy
  • Chelation Therapy
  • Oxytocin Therapy
  • Others

Drug

  • Anticonvulsants
  • Carbamazepine
  • Oxcarbazepine
  • Lamotrigine
  • Antipsychotics
  • Amisulpride.
  • Aripiprazole.
  • Asenapine
  • Insomnia Drugs
  • Triazolam
  • Estazolam
  • SSRIs
  • Citalopram
  • Dapoxetine
  • Escitalopram
  • Stimulants
  • Others

Distribution Channel

  • Hospital & Clinics
  • Retail Pharmacies
  • Online Pharmacies

Autism Therapy Market Regional Analysis/Insights

The autism therapy market is analyzed and market size insights and trends are provided by age group, type, treatment type, drug and distribution channel as referenced above.

The countries covered in the autism therapy market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the autism therapy market due to increasing R&D activities and the launching several new products through mergers and strategic partnerships in this region. Also, the increasing awareness about the availability of numerous therapies to treat patients with autism spectrum disorders in this region.    

Asia-Pacific is expected to witness significant growth due to the wide presence of major market players and strategic initiatives undertaken by them to develop and commercialize several new products to treat patients. For instance, Teijin Pharma and Hamamatsu Medical University confirmed the safety, efficiency, and tolerability of oxytocin nasal spray for treating patients with an autism spectrum disorder in 2022.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The autism therapy market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for autism therapy market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the autism therapy market. The data is available for historic period 2011-2021.

Competitive Landscape and Autism Therapy Market Share Analysis

The autism therapy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to autism therapy market.

Some of the major players operating in the autism therapy market are:

  • Pfizer Inc. (U.S.)
  • Lilly (U.S.)
  • Abbvie, Inc (U.S.)
  • Merck & Co., Inc (U.S.).
  • Teva Pharmaceutical Industries Ltd.(Israel)
  • Novartis AG (Switzerland)
  • Johnson & Johnson Services, Inc (U.S.).
  • Hopebridge, LLC (U.S.)
  • Bristol-Myers Squibb Company (U.S.)
  • Otsuka America Pharmaceutical, Inc (Japan)
  • Curemark, LLC (U.S.).
  • Sosei Group Corporation (Japan)
  • Sun Pharmaceutical Industries Ltd.(India)
  • Mylan N.V. (U.S.).
  • Endo International plc (Ireland)
  • F. Hoffmann-La Roche Ltd (Switzerland)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The autism therapy market size will be worth USD 3.42 billion by 2030.
The growth rate of the autism therapy market is 6.60% in the forecast period by 2030.
Major companies in the autism therapy market are Pfizer Inc.(U.S.), Lilly (U.S.), Abbvie, Inc (U.S.), Merck & Co., Inc (U.S.)., Teva Pharmaceutical Industries Ltd.(Israel), Novartis AG (Switzerland), Johnson & Johnson Services, Inc (U.S.)., Hopebridge, LLC (U.S.)., etc.
Age group, type, treatment type, drug, and distribution channel are the factors on which the autism therapy market research is based.
The increasing rate of the autistic population & increasing R&D activities associated with autism therapy are the growth drivers of the autism therapy market.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials